Clinical Trial Update: Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two loading regimens of Sunitinib or Bevacizumab alternating with cisplatin and gemcitabine as induction therapy for locally advanced n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Sunitinib (sunitinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED